Non-invasive simulated electrical and measured mechanical indices predict response to cardiac resynchronization therapy.
Cardiac resynchronization therapy
Computer models
Lead optimization
Machine learning
Journal
Computers in biology and medicine
ISSN: 1879-0534
Titre abrégé: Comput Biol Med
Pays: United States
ID NLM: 1250250
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
received:
09
06
2021
revised:
09
09
2021
accepted:
09
09
2021
pubmed:
2
10
2021
medline:
5
11
2021
entrez:
1
10
2021
Statut:
ppublish
Résumé
Cardiac Resynchronization Therapy (CRT) in dyssynchronous heart failure patients is ineffective in 20-30% of cases. Sub-optimal left ventricular (LV) pacing location can lead to non-response, thus there is interest in LV lead location optimization. Invasive acute haemodynamic response (AHR) measurements have been used to optimize the LV pacing location during CRT implantation. In this manuscript, we aim to predict the optimal lead location (AHR>10%) with non-invasive computed tomography (CT) based measures of cardiac anatomical and mechanical properties, and simulated electrical activation times. Non-invasive measurements from CT images and ECG were acquired from 34 patients indicated for CRT upgrade. The LV lead was implanted and AHR was measured at different pacing sites. Computer models of the ventricles were used to simulate the electrical activation of the heart, track the mechanical motion throughout the cardiac cycle and measure the wall thickness of the LV on a patient specific basis. We tested the ability of electrical, mechanical and anatomical indices to predict the optimal LV location. Electrical (RV-LV delay) and mechanical (time to peak contraction) indices were correlated with an improved AHR, while wall thickness was not predictive. A logistic regression model combining RV-LV delay and time to peak contraction was able to predict positive response with 70 ± 11% accuracy and AUROC curve of 0.73. Non-invasive electrical and mechanical indices can predict optimal epicardial lead location. Prospective analysis of these indices could allow clinicians to test the AHR at fewer pacing sites and reduce time, costs and risks to patients.
Sections du résumé
BACKGROUND
Cardiac Resynchronization Therapy (CRT) in dyssynchronous heart failure patients is ineffective in 20-30% of cases. Sub-optimal left ventricular (LV) pacing location can lead to non-response, thus there is interest in LV lead location optimization. Invasive acute haemodynamic response (AHR) measurements have been used to optimize the LV pacing location during CRT implantation. In this manuscript, we aim to predict the optimal lead location (AHR>10%) with non-invasive computed tomography (CT) based measures of cardiac anatomical and mechanical properties, and simulated electrical activation times.
METHODS
Non-invasive measurements from CT images and ECG were acquired from 34 patients indicated for CRT upgrade. The LV lead was implanted and AHR was measured at different pacing sites. Computer models of the ventricles were used to simulate the electrical activation of the heart, track the mechanical motion throughout the cardiac cycle and measure the wall thickness of the LV on a patient specific basis.
RESULTS
We tested the ability of electrical, mechanical and anatomical indices to predict the optimal LV location. Electrical (RV-LV delay) and mechanical (time to peak contraction) indices were correlated with an improved AHR, while wall thickness was not predictive. A logistic regression model combining RV-LV delay and time to peak contraction was able to predict positive response with 70 ± 11% accuracy and AUROC curve of 0.73.
CONCLUSION
Non-invasive electrical and mechanical indices can predict optimal epicardial lead location. Prospective analysis of these indices could allow clinicians to test the AHR at fewer pacing sites and reduce time, costs and risks to patients.
Identifiants
pubmed: 34598070
pii: S0010-4825(21)00666-1
doi: 10.1016/j.compbiomed.2021.104872
pii:
doi:
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
104872Subventions
Organisme : Wellcome Trust
ID : 203148/Z/16/Z
Pays : United Kingdom
Informations de copyright
Copyright © 2021. Published by Elsevier Ltd.